Participated in VelaVigo's over $60M Pre-A+ financing round for antibody/ADC discovery and development, led by Shunwei Capital and Everest VC.
VelaVigo is a Shanghai-based biotech company focused on globally innovative large molecule discovery and development, building full capabilities covering the entire value chain of drug discovery and development
VelaVigo is a Shanghai-based biotech company focused on globally innovative large molecule discovery and development, building full capabilities covering the entire value chain of drug discovery and development.